Cedar Park, TX is no longer just a suburb of Austin—it’s becoming the epicenter of Central Texas’ emerging life science cluster, thanks in large part to the innovation of local pioneers like Zeteo Biomedical.

This week, Zeteo announced the issuance of new U.S. and EU patents for its cutting-edge drug delivery technologies. Their ZTech™ platform enables compact, intuitive, and patient-friendly delivery of drugs and biologics through nasal, ophthalmic, and sublingual routes. These platforms are critical for treating everything from neurological conditions to infectious diseases—non-invasively and even in space.

What makes this even more significant is location. By anchoring advanced biomed innovation in Cedar Park, Zeteo is helping shift the center of gravity for life sciences in the Austin MSA to the north. With global pharma partners, a robust IP portfolio, and a focus on commercial scalability, Zeteo is laying the foundation for Cedar Park to lead the region’s next economic evolution—Austin’s first life science cluster, rooted right here.

Learn more at Zeteo Biomedical Secures Global Patents and keep watching Cedar Park. The future of biotech in Texas is taking shape here.